About ULTRAGENYX PHARMACEUTICAL INC.
Ultragenyx is a biopharmaceutical company focused on developing and delivering treatments for rare and ultrarare genetic diseases where no current therapies exist. The company emphasizes innovation and patient-centric approaches in its research and development.
Development of therapies for rare and ultrarare genetic diseasesExploration of multiple drug modalities to select optimal treatment strategiesRobust and diverse clinical pipeline in rare disease
Is this your company?
Claim ULTRAGENYX PHARMACEUTICAL INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim ULTRAGENYX PHARMACEUTICAL INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.